NCT04565431 - Examining Effects of Tysabri on Cognitive Fatigue Using fMRI | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

Tysabri

Participants with RRMS who are planning to begin treatment with Tysabri will be compared to a group of healthy individuals who are matched for age, gender, and education.

Trial Locations (1)

07052

RECRUITING

Kessler Foundation, West Orange